Warning letter
Nam & Nam, Inc. t/a Sam Sung Tofu: warning letter of Jan 24, 2017
FDA warning letter 506791 · Baltimore District Office
Key facts
| Reference number | 506791 |
|---|---|
| Company | Nam & Nam, Inc. t/a Sam Sung Tofu |
| Subject | CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Jan 24, 2017 |
| Posted date | Jan 31, 2017 |
| Issuing office | Baltimore District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.13(n), 101, 101.7, 117, 101.15(c)(1), 101.9, 101.7(j)(1), 101.9(c)(7)(i), 110.20(b)(7), 110.35(a), 110.35(b)(1), 110.37(b)(3) and 4 more |
| Inspection city | Washington |
| Inspection ZIP | 20002 |
| Inspection start date | Jul 21, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: